What is the share price of Gufic Biosciences Ltd (GUFICBIO) today?

The share price of GUFICBIO as on 18th July 2025 is ₹384.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

What is the return on Gufic Biosciences Ltd (GUFICBIO) share?

The past returns of Gufic Biosciences Ltd (GUFICBIO) share are Past 1 week: 7.77% Past 1 month: 3.60% Past 3 months: 11.86% Past 6 months: -15.35% Past 1 year: 9.72% Past 3 years: 91.24% Past 5 years: 335.09%

What are the peers or stocks similar to Gufic Biosciences Ltd (GUFICBIO)?

The peers or stocks similar to Gufic Biosciences Ltd (GUFICBIO) include: Gufic Biosciences Ltd Sun Pharmaceutical Industries Ltd Cipla Ltd Torrent Pharmaceuticals Ltd Mankind Pharma Ltd Dr Reddy's Laboratories Ltd

What is the dividend yield % of Gufic Biosciences Ltd (GUFICBIO) share?

The current dividend yield of Gufic Biosciences Ltd (GUFICBIO) is 0.03.

What is the market cap of Gufic Biosciences Ltd (GUFICBIO) share?

Market capitalization, short for market cap , is the market value of a publicly traded company's outstanding shares. The market cap of Gufic Biosciences Ltd (GUFICBIO) is ₹3865.20 Cr as of 18th July 2025.

What is the 52 week high and low of Gufic Biosciences Ltd (GUFICBIO) share?

The 52-week high of Gufic Biosciences Ltd (GUFICBIO) is ₹504.25 and the 52-week low is ₹298.80.

What is the PE and PB ratio of Gufic Biosciences Ltd (GUFICBIO) stock?

The P/E (price-to-earnings) ratio of Gufic Biosciences Ltd (GUFICBIO) is 55.49. The P/B (price-to-book) ratio is 7.26.

Which sector does Gufic Biosciences Ltd (GUFICBIO) belong to?

Gufic Biosciences Ltd (GUFICBIO) belongs to the Health Care sector & Pharmaceuticals sub-sector.

How to buy Gufic Biosciences Ltd (GUFICBIO) shares?

You can directly buy Gufic Biosciences Ltd (GUFICBIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.

Gufic Biosciences Ltd

GUFICBIO Share Price

384.400.27% (-1.05)

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹3,865 cr, stock is ranked 878

High Risk

Stock is 3.06x as volatile as Nifty

GUFICBIO Stock Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Bad

The stock is overpriced and in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care

Pharmaceuticals

Smallcap

With a market cap of ₹3,865 cr, stock is ranked 878

High Risk

Stock is 3.06x as volatile as Nifty

GUFICBIO Performance & Key Metrics

No LabelNo Label	PB RatioPB Ratio	Dividend YieldDiv. Yield
55.50	7.26	0.03%

Sector PESector PE	Sector PBSector PB	Sector Div YldSctr Div Yld
37.08	6.54	0.76%

GUFICBIO Analyst Ratings & Forecast

—

Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

GUFICBIO Company Profile

Gufic Biosciences Limited manufactures pharmaceuticals, medicinal chemicals and botanical products. The Company's segments include Formulations, Bulk Drugs and Consumer.

Investor Presentation

View older View older

May 30, 2025

PDF

View Older Presentations

GUFICBIO Similar Stocks (Peers)

Compare with peers Compare with peers

GUFICBIO Similar Stocks (Peers)

Compare with peers Compare with peers

Sun Pharmaceutical Industries Ltd

SUNPHARMA

PE Ratio

37.40

1Y Return

6.23%

Buy Reco %

84.85

Cipla Ltd

CIPLA

PE Ratio

22.71

1Y Return

1.62%

Buy Reco %

68.75

Torrent Pharmaceuticals Ltd

TORNTPHARM

PE Ratio

62.06

1Y Return

15.14%

Buy Reco %

70.83

Mankind Pharma Ltd

MANKIND

PE Ratio

54.71

1Y Return

24.01%

Buy Reco %

81.25

Dr Reddy's Laboratories Ltd

DRREDDY

PE Ratio

18.59

1Y Return

5.70%

Buy Reco %

48.39

Compare with Peers

GUFICBIO Forecast

GUFICBIO Forecasts

GUFICBIO

Income

Balance Sheet

Cash Flow

GUFICBIO Income Statement

Financial Year		FY 2024		FY 2025	TTM
Total Revenue	808.85	823.43	823.43
Raw Materials	389.32	685.11	685.11
Power & Fuel Cost	17.79
Employee Cost	109.63
Selling & Administrative Expenses	103.90
Operating & Other expenses	40.15
EBITDA	148.06	138.32	138.32
Depreciation/Amortization	17.02	21.06	21.07
PBIT	131.04	117.26	117.25
Interest & Other Items	15.36	23.11	23.11
PBT	115.68	94.15	94.14
Taxes & Other Items	29.54	24.49	24.50
Net Income	86.14	69.66	69.64
EPS	8.59	6.95	6.94
DPS	0.10	0.10	0.10
Payout ratio	0.01	0.01	0.01

Quarter		jun 2023		sep 2023		dec 2023		mar 2024	jun 2024	sep 2024	dec 2024	mar 2025
Total Revenue	195.56	215.21	202.20	195.87	204.07	204.29	209.66	205.41
Operating & Other expenses	159.20	175.50	165.32	160.77	167.03	165.56	173.87	178.65
EBITDA	36.36	39.71	36.88	35.10	37.04	38.73	35.79	26.76
Depreciation/Amortization	4.24	4.30	4.14	4.34	4.31	4.30	4.62	7.84
PBIT	32.12	35.41	32.74	30.76	32.73	34.43	31.17	18.92
Interest & Other Items	4.07	4.46	3.18	3.65	4.62	5.18	4.91	8.40
PBT	28.05	30.95	29.56	27.11	28.11	29.25	26.26	10.52
Taxes & Other Items	7.43	7.73	7.30	7.07	7.25	7.49	6.96	2.80
Net Income	20.62	23.22	22.26	20.04	20.86	21.76	19.30	7.72
EPS	2.13	2.39	2.23	2.00	2.08	2.17	1.93	0.77

Financial Year		FY 2024
Cash from Operating Activities	-7.46
Cash from Investing Activities	-102.39
Cash from Financing Activities	82.38
Net Change in Cash	-27.47
Changes in Working Capital	-157.26
Capital Expenditures	112.69
Free Cash Flow	-120.15

GUFICBIO Company Updates

FY 2025FY 2025

Annual Report Pending

Investor Presentation

May 30PDF

Feb 14PDF

Nov 14PDF

FY 2024FY 2024

Annual report

PDF

Investor Presentation

Aug 11PDF

FY 2023FY 2023

Annual report

PDF

Investor Presentation

May 29PDF

Nov 11PDF

Aug 11PDF

FY 2022FY 2022

Annual report

PDF

FY 2021FY 2021

Annual report

PDF

Investor Presentation

Nov 11PDF

FY 2020FY 2020

Annual report

PDF

FY 2019FY 2019

Annual report

PDF

FY 2018FY 2018

Annual report

PDF

FY 2017FY 2017

Annual report

PDF

FY 2016FY 2016

Annual report

PDF

FY 2015FY 2015

Annual report

PDF

GUFICBIO Stock Peers

GUFICBIO Past Performance & Peer Comparison

Comparing 3 stocks from
Health CarePharmaceuticals

Valuation

Technical

Forecast

Compare valuation-basic on Screener

Stock	PE RatioPE Ratio	PB RatioPB Ratio	Div. YieldDividend Yield
Gufic Biosciences Ltd	55.49	7.26	0.03%
Sun Pharmaceutical Industries Ltd	37.40	5.64	0.94%
Cipla Ltd	22.71	3.83	1.08%
Torrent Pharmaceuticals Ltd	62.06	15.63	0.91%

Stock	Buy Reco %Buy Reco %	Upside %Upside %	1Y Fwd EPS Grwth1Y Forward EPS Growth
Gufic Biosciences Ltd	Pro
Sun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd

Stock	VolatilityVolatility	RSI–14DRSI – 14D	Price Mom RankPrice Momentum Rank
Gufic Biosciences Ltd	41.37%	70.58	Pro
Sun Pharmaceutical Industries Ltd	20.71%	55.22
Cipla Ltd	22.85%	42.08
Torrent Pharmaceuticals Ltd	23.76%	66.37

GUFICBIO Stock Price Comparison

Compare GUFICBIO with any stock or ETF

GUFICBIO

GUFICBIO Holdings

GUFICBIO Shareholdings

GUFICBIO Promoter Holdings Trend

GUFICBIO Institutional Holdings Trend

GUFICBIO Shareholding Pattern

GUFICBIO Shareholding History

Foreign Institutions

Mutual Funds Invested in GUFICBIO

No mutual funds holding trends are available

Top 5 Mutual Funds holding Gufic Biosciences Ltd

Funds (Top 5)	Market-cap held	Weight	3M holding change	Portfolio rank (3M change)
Motilal Oswal Small Cap Fund - Growth - Direct Plan Growth	1.3379%	0.99%	-0.13%	46/59 (-7)
SBI Healthcare Opportunities Fund - Growth - Direct Plan Growth	0.9419%	0.95%	0.01%	30/34 (-1)
ICICI Prudential Smallcap Fund - Growth - Direct Plan Growth	0.4149%	0.19%	-0.02%	97/130 (0)

Compare 3-month MF holding change on Screener

GUFICBIO Insider Trades & Bulk Stock Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases containing GUFICBIO stock

Looks like this stock is not in any smallcase yet.

GUFICBIO Events

GUFICBIO Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

GUFICBIO Dividend Trend

No dividend trend available

GUFICBIO Upcoming Dividends

No upcoming dividends are available

GUFICBIO Past Dividends

Cash Dividend

Ex DateEx DateSep 17, 2024

Final

Final | Div/Share: ₹0.10

Dividend/Share

₹0.10

Ex DateEx Date

Sep 17, 2024

Cash Dividend

Ex DateEx DateSep 21, 2023

Final

Final | Div/Share: ₹0.10

Dividend/Share

₹0.10

Ex DateEx Date

Sep 21, 2023

Cash Dividend

Ex DateEx DateAug 24, 2022

Final

Final | Div/Share: ₹0.10

Dividend/Share

₹0.10

Ex DateEx Date

Aug 24, 2022

Cash Dividend

Ex DateEx DateSep 9, 2021

Final

Final | Div/Share: ₹0.10

Dividend/Share

₹0.10

Ex DateEx Date

Sep 9, 2021

Cash Dividend

Ex DateEx DateNov 3, 2020

Final

Final | Div/Share: ₹0.05

Dividend/Share

₹0.05

Ex DateEx Date

Nov 3, 2020

GUFICBIO Corp. Actions

Hmm, looks like data is unavailable here. Please come back after some time

No upcoming announcements are available

Update-Acquisition/Scheme/Sale/Disposal-XBRL

Announced OnJul 15, 2025

Gufic Biosciences Limited has informed t

Gufic Biosciences Limited has informed t Download

Link

Download

Announced On

Jul 15, 2025

Company Update

Announced OnJul 15, 2025

Gufic Biosciences Ltd - 509079 - Update

Gufic Biosciences Ltd - 509079 - Update Download

Link

Download

Announced On

Jul 15, 2025

General Updates

Announced OnJul 15, 2025

Gufic Biosciences Limited has informed t

Gufic Biosciences Limited has informed t Download

Link

Download

Announced On

Jul 15, 2025

Company Update

Announced OnJul 9, 2025

Gufic Biosciences Ltd - 509079 - Complia

Gufic Biosciences Ltd - 509079 - Complia Download

Link

Download

Announced On

Jul 9, 2025

Certificate under SEBI (Depositories and Participants) Regulations, 2018

Announced OnJul 9, 2025

Gufic Biosciences Limited has informed t

Gufic Biosciences Limited has informed t Download

Link

Download

Announced On

Jul 9, 2025

Gufic Biosciences Limited Vs N/A

Order DateDec 3, 2020

NCLT | CP(CAA)/1052/MB/2020INCA(CAA)/101

NCLT | CP(CAA)/1052/MB/2020INCA(CAA)/1013/MB/2020

Download

Link

Download

Order Date

Dec 3, 2020

Gufic Biosciences Limited Vs N/A

Order DateNov 26, 2020

NCLT | CP(CAA)/1052/MB/2020INCA(CAA)/101

NCLT | CP(CAA)/1052/MB/2020INCA(CAA)/1013/MB/2020

Download

Link

Download

Order Date

Nov 26, 2020

GUFICBIO Stock News & Opinions

Corporate

Gufic BioSciences appoints senior management personnel

Gufic BioSciences has appointed Rajesh Kaul as Senior President - Sparsh Cluster, Senior Management Personnel of the Company with effect from 04 July 2025. Powered by Capital Market - Live

2 weeks agoCapital Market - Live

Earnings

Gufic BioSciences consolidated net profit declines 61.50% in the March 2025 quarter

Net profit of Gufic BioSciences declined 61.50% to Rs 7.72 crore in the quarter ended March 2025 as against Rs 20.05 crore during the previous quarter ended March 2024. Sales rose 5.14% to Rs 205.02 crore in the quarter ended March 2025 as against Rs 194.99 crore during the previous quarter ended March 2024. For the full year,net profit declined 19.14% to Rs 69.65 crore in the year ended March 2025 as against Rs 86.14 crore during the previous year ended March 2024. Sales rose 1.63% to Rs 819.81 crore in the year ended March 2025 as against Rs 806.67 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales205.02194.99 5 819.81806.67 2 OPM %12.8717.55 -16.4318.08 - PBDT18.3731.46 -42 115.21132.69 -13 PBT10.5227.12 -61 94.14115.67 -19 NP7.7220.05 -61 69.6586.14 -19 Powered by Capital Market - Live

1 month agoCapital Market - Live

Earnings

Gufic BioSciences standalone net profit declines 60.25% in the March 2025 quarter

Net profit of Gufic BioSciences declined 60.25% to Rs 7.97 crore in the quarter ended March 2025 as against Rs 20.05 crore during the previous quarter ended March 2024. Sales rose 5.14% to Rs 205.02 crore in the quarter ended March 2025 as against Rs 194.99 crore during the previous quarter ended March 2024. For the full year,net profit declined 18.82% to Rs 69.93 crore in the year ended March 2025 as against Rs 86.14 crore during the previous year ended March 2024. Sales rose 1.63% to Rs 819.81 crore in the year ended March 2025 as against Rs 806.67 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales205.02194.99 5 819.81806.67 2 OPM %12.9917.55 -16.4618.08 - PBDT18.6131.46 -41 115.48132.70 -13 PBT10.7727.12 -60 94.42115.68 -18 NP7.9720.05 -60 69.9386.14 -19 Powered by Capital Market - Live

1 month agoCapital Market - Live

Corporate

Board of Gufic BioSciences recommends final dividend

Gufic BioSciences announced that the Board of Directors of the Company at its meeting held on 30 May 2025, inter alia, have recommended the final dividend of Rs 0.1 per equity Share (i.e. 10%) , subject to the approval of the shareholders.Powered by Capital Market - Live

1 month agoCapital Market - Live

Corporate

Gufic BioSciences to announce Quarterly Result

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 30 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live

Earnings

Gufic BioSciences standalone net profit declines 13.21% in the December 2024 quarter

Net profit of Gufic BioSciences declined 13.21% to Rs 19.32 crore in the quarter ended December 2024 as against Rs 22.26 crore during the previous quarter ended December 2023. Sales rose 2.98% to Rs 207.79 crore in the quarter ended December 2024 as against Rs 201.78 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales207.79201.78 3 OPM %16.3418.07 - PBDT30.9033.70 -8 PBT26.2829.56 -11 NP19.3222.26 -13 Powered by Capital Market - Live

5 months agoCapital Market - Live

Corporate

Gufic BioSciences to announce Quarterly Result

Gufic BioSciences will hold a meeting of the Board of Directors of the Company on 14 February 2025.Powered by Capital Market - Live

5 months agoCapital Market - Live

Spotlight

Gufic Biosciences tumbles after Q2 PAT drops 6% YoY to Rs 22 cr

Profit before tax (PBT) fell 5.46% YoY to Rs 29.25 crore during the quarter. Total expenses fell 5% to Rs 175.04 crore in Q2 FY25 as compared with Rs 184.26 crore in Q2 FY24. Cost of material consumed stood at Rs 74.93 crore (down 21.36% YoY), employee benefit expenses stood at Rs 28.47 crore (up 6.31% YoY), finance cost was at Rs 5.17 crore (up 15.92% YoY) during the period under review. EBITDA stood at Rs 38.7 crore in Q2 FY25, registering the de-growth of 2.52% as compared with Rs 39.7 crore in Q2 FY24. EBITDA margin increased 18.95% in Q2 FY25 as compared with18.47% in Q2 FY24. Gufic Biosciences is a pharmaceutical company engaged in research and development, manufacturing, marketing, distribution, and sale of pharmaceutical and herbal products. Its products include a wide range of active pharmaceutical ingredients (APIs). Gufic is a leading manufacturer of lyophilized injections, boasting a fully automated lyophilization plant.Powered by Capital Market - Live

7 months agoCapital Market - Live

Spotlight

Gufic Biosciences Q2 PAT drops 6% YoY to Rs 22 cr

8 months agoCapital Market - Live

Earnings

Gufic BioSciences standalone net profit declines 6.16% in the September 2024 quarter

Net profit of Gufic BioSciences declined 6.16% to Rs 21.78 crore in the quarter ended September 2024 as against Rs 23.21 crore during the previous quarter ended September 2023. Sales declined 4.98% to Rs 204.18 crore in the quarter ended September 2024 as against Rs 214.87 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales204.18214.87 -5 OPM %18.9218.32 - PBDT33.5735.24 -5 PBT29.2730.94 -5 NP21.7823.21 -6 Powered by Capital Market - Live

8 months agoCapital Market - Live

Frequently asked questions

What is the share price of Gufic Biosciences Ltd (GUFICBIO) today?
The share price of GUFICBIO as on 18th July 2025 is ₹384.40. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.
What is the return on Gufic Biosciences Ltd (GUFICBIO) share?
The past returns of Gufic Biosciences Ltd (GUFICBIO) share are
- Past 1 week: 7.77%
- Past 1 month: 3.60%
- Past 3 months: 11.86%
- Past 6 months: -15.35%
- Past 1 year: 9.72%
- Past 3 years: 91.24%
- Past 5 years: 335.09%
What are the peers or stocks similar to Gufic Biosciences Ltd (GUFICBIO)?
The peers or stocks similar to Gufic Biosciences Ltd (GUFICBIO) include:
What is the dividend yield % of Gufic Biosciences Ltd (GUFICBIO) share?
The current dividend yield of Gufic Biosciences Ltd (GUFICBIO) is 0.03.
What is the market cap of Gufic Biosciences Ltd (GUFICBIO) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Gufic Biosciences Ltd (GUFICBIO) is ₹3865.20 Cr as of 18th July 2025.
What is the 52 week high and low of Gufic Biosciences Ltd (GUFICBIO) share?
The 52-week high of Gufic Biosciences Ltd (GUFICBIO) is ₹504.25 and the 52-week low is ₹298.80.
What is the PE and PB ratio of Gufic Biosciences Ltd (GUFICBIO) stock?
The P/E (price-to-earnings) ratio of Gufic Biosciences Ltd (GUFICBIO) is 55.49. The P/B (price-to-book) ratio is 7.26.
Which sector does Gufic Biosciences Ltd (GUFICBIO) belong to?
Gufic Biosciences Ltd (GUFICBIO) belongs to the Health Care sector & Pharmaceuticals sub-sector.
How to buy Gufic Biosciences Ltd (GUFICBIO) shares?
You can directly buy Gufic Biosciences Ltd (GUFICBIO) shares on Tickertape. Simply sign up, connect your demat account and place your order.